Skip to Content

93 B9 (Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base))

Pill with imprint 93 B9 is White, Capsule-shape and has been identified as Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual) 2 mg (base) / 0.5 mg (base). It is supplied by Teva Pharmaceuticals USA Inc..

Buprenorphine/naloxone is used in the treatment of opiate dependence and belongs to the drug class narcotic analgesic combinations. Risk cannot be ruled out during pregnancy. Buprenorphine/naloxone 2 mg (base) / 0.5 mg (base) is classified as a Schedule 3 controlled substance under the Controlled Substance Act (CSA).

Images for 93 B9

Buprenorphine hydrochloride and naloxone hydrochloride (sublingual) 2 mg (base) / 0.5 mg (base) 93 B9

Buprenorphine Hydrochloride and Naloxone Hydrochloride (Sublingual)

Imprint
93 B9
Strength
2 mg (base) / 0.5 mg (base)
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Narcotic analgesic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
3 - Moderate abuse potential
Labeler / Supplier
Teva Pharmaceuticals USA Inc.
National Drug Code (NDC)
00093-5720

Get help with Imprint Code FAQs.

Related Images for "93 B9"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.